Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05144997 |
Title | Lorlatinib Continuation Study |
Recruitment | Active, not recruiting |
Gender | both |
Phase | FDA approved |
Variant Requirements | Yes |
Sponsors | Pfizer |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | FRA | ESP |